The global blood glucose monitoring systems market is expected to grow from USD 11.61 billion in 2019 to USD 20.96 billion by 2027, at a CAGR of 7.66% during the forecast period 2020-2027.
Blood glucose monitoring systems are economically profitable and essential for precise diagnosis and therapy. The systems are utilized to estimate blood sugar levels. It is a critical step for diabetes therapy. Blood glucose monitoring systems also restrict additional health conditions, such as retinopathy, neuropathy, and cardiovascular diseases. There are different varieties of blood glucose monitors available in the market ranging in price, length of testing time, size, and ease of use. The market has significantly benefited from early detection of hyperglycemic and hypo diabetes and constant technological advancements. Rapidly changing lifestyles, such as consumption of alcohol and smoking and unhealthy foods, are contributing to the increase in the number of diabetes patients worldwide. Obesity is also one of the significant factors that result in diabetes. Essential factors propelling the blood glucose monitoring systems market are the growing incidence of diabetes and the rising geriatric population prone to diabetes. The market is further driven by new product launches, awareness about diabetes preventive care, and supportive government initiatives.
This study delivers a comprehensive analysis of products, end-users and regions. The product segment includes continuous blood glucose monitoring devices, self-monitoring blood glucose devices. Continuous blood glucose monitoring device segment is further classified into lancets, transmitter & receiver and sensors. Self-monitoring blood glucose device segment is further classified into testing strips and blood glucose meter. The continuous blood glucose monitoring devices segment is anticipated to record the highest growth over the forecast period. Continuous blood glucose monitoring devices are utilized by patients that need regular blood sugar reading. Continuous blood glucose monitoring products are beneficial in analyzing glucose level patterns by offering real-time and continuous blood sugar readings. Continuous blood glucose monitoring devices operate through a small sensor that is implanted under the skin. The sensor estimates the sugar level, and the transmitter wirelessly transmits the data to a monitor. The end-user segment includes diagnostic centers, home care, clinics and hospitals.The home care segment is anticipated to show the highest growth over the forecast period. Home-based glucose monitoring has been transformed by self-monitoring devices and solutions. It is the most widely applied method of short-term glucose monitoring across the globe. People with or without diabetes can measure blood sugar levels with comfort and ease at their homes. Based on the reading, patients can monitor the effects of the therapy, such as insulin, exercise, diet, and stress management.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North America is expected to show the highest growth in the blood glucose monitoring systems market over the forecast period due to its well-established healthcare sector. The high cost of therapy and the growing prevalence of obesity is also anticipated to propel the growth in the region, along with new product launches and technological advancements.
Some of the notable players in the global blood glucose monitoring systems market are Abbott, Johnson & Johnson Services Inc., Dexcom Inc., B. Braun Melsungen AG, Sanofi, Prodigy Diabetes Care LLC., Nova Biomedical, BD, TERUMO Corporation, Medtronic, PHC Holdings Corporation, NIPRO, ACON Laboratories Inc., Roper Technologies Inc., F. Hoffmann-La Roche Ltd., ARKRAY Inc., Novo Nordisk A/S, Bayer AG and Ypsomed.
This study forecasts revenue growth at global, regional, and country levels from 2020 to 2027. Fior Markets has segmented the market based on below-mentioned segments:
Global Blood Glucose Monitoring Systems Market Analysis And Forecast, By Product
Global Blood Glucose Monitoring Systems Market Analysis And Forecast, By End-User
Global Blood Glucose Monitoring Systems Market Analysis And Forecast, By Regional Analysis
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Product
4.3.2. Market Attractiveness Analysis By End-User
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Growing levels of the diabetic community
5.3. Restraints
5.3.1. Varying economic concentration in the emerging economies
5.3.2. Stringent regulations
5.4. Opportunities
5.4.1. Technological innovation and advancements
5.5. Challenges
5.5.1. Monitoring systems can be replaced for more affordable ones
6. Global Blood Glucose Monitoring Systems Market Analysis and Forecast, By Product
6.1. Segment Overview
6.2. Continuous Blood Glucose Monitoring Devices
6.2.1. Lancets
6.2.2. Transmitter & Receiver
6.2.3. Sensors
6.3. Self-Monitoring Blood Glucose Devices
6.3.1. Testing Strips
6.3.2. Blood Glucose Meter
7. Global Blood Glucose Monitoring Systems MarketAnalysis and Forecast, By End-User
7.1. Segment Overview
7.2. Diagnostic Centers
7.3. Home Care
7.4. Clinics
7.5. Hospitals
8. Global Blood Glucose Monitoring Systems MarketAnalysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Blood Glucose Monitoring Systems Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Blood Glucose Monitoring Systems Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. End-User Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Abbott
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Johnson & Johnson Services Inc.
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Dexcom Inc.
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. B. Braun Melsungen AG
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. Sanofi
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Prodigy Diabetes Care LLC.
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Nova Biomedical
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. BD
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. TERUMO Corporation
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Medtronic
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
10.11. PHC Holdings Corporation
10.11.1. Business Overview
10.11.2. Company Snapshot
10.11.3. Company Market Share Analysis
10.11.4. Company Product Portfolio
10.11.5. Recent Developments
10.11.6. SWOT Analysis
10.12. NIPRO
10.12.1. Business Overview
10.12.2. Company Snapshot
10.12.3. Company Market Share Analysis
10.12.4. Company Product Portfolio
10.12.5. Recent Developments
10.12.6. SWOT Analysis
10.13. ACON Laboratories Inc.
10.13.1. Business Overview
10.13.2. Company Snapshot
10.13.3. Company Market Share Analysis
10.13.4. Company Product Portfolio
10.13.5. Recent Developments
10.13.6. SWOT Analysis
10.14. Roper Technologies Inc.
10.14.1. Business Overview
10.14.2. Company Snapshot
10.14.3. Company Market Share Analysis
10.14.4. Company Product Portfolio
10.14.5. Recent Developments
10.14.6. SWOT Analysis
10.15. F. Hoffmann-La Roche Ltd.
10.15.1. Business Overview
10.15.2. Company Snapshot
10.15.3. Company Market Share Analysis
10.15.4. Company Product Portfolio
10.15.5. Recent Developments
10.15.6. SWOT Analysis
10.16. ARKRAY Inc.
10.16.1. Business Overview
10.16.2. Company Snapshot
10.16.3. Company Market Share Analysis
10.16.4. Company Product Portfolio
10.16.5. Recent Developments
10.16.6. SWOT Analysis
10.17. Novo Nordisk A/S
10.17.1. Business Overview
10.17.2. Company Snapshot
10.17.3. Company Market Share Analysis
10.17.4. Company Product Portfolio
10.17.5. Recent Developments
10.17.6. SWOT Analysis
10.18. Bayer AG
10.18.1. Business Overview
10.18.2. Company Snapshot
10.18.3. Company Market Share Analysis
10.18.4. Company Product Portfolio
10.18.5. Recent Developments
10.18.6. SWOT Analysis
10.19. Ypsomed
10.19.1. Business Overview
10.19.2. Company Snapshot
10.19.3. Company Market Share Analysis
10.19.4. Company Product Portfolio
10.19.5. Recent Developments
10.19.6. SWOT Analysis
List of Table
1. Global Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
2. GlobalContinuous Blood Glucose Monitoring Devices, Blood Glucose Monitoring SystemsMarket, By Region, 2017-2027 (USD Billion) (K Units)
3. GlobalSelf-Monitoring Blood Glucose Devices, Blood Glucose Monitoring Systems Market, By Region, 2017-2027 (USD Billion) (K Units)
4. Global Blood Glucose Monitoring Systems Market, ByEnd-User, 2017-2027 (USD Billion) (K Units)
5. GlobalDiagnostic Centers, Blood Glucose Monitoring Systems Market, By Region, 2017-2027 (USD Billion) (K Units)
6. Global Home Care, Blood Glucose Monitoring Systems Market, By Region, 2017-2027 (USD Billion) (K Units)
7. Global Clinics, Blood Glucose Monitoring Systems Market, By Region, 2017-2027 (USD Billion) (K Units)
8. Global Hospitals, Blood Glucose Monitoring Systems Market, By Region, 2017-2027 (USD Billion) (K Units)
9. North America Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
10. North America Blood Glucose Monitoring Systems Market, ByEnd-User, 2017-2027 (USD Billion) (K Units)
11. U.S. Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
12. U.S. Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
13. Canada Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
14. CanadaBlood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
15. Mexico Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
16. Mexico Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
17. Europe Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
18. Europe Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
19. Germany Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
20. Germany Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
21. France Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
22. France Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
23. U.K. Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
24. U.K. Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
25. Italy Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
26. Italy Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
27. Spain Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
28. Spain Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
29. Asia Pacific Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
30. Asia Pacific Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
31. Japan Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
32. Japan Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
33. China Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
34. China Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
35. India Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
36. India Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
37. South America Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
38. South America Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
39. Brazil Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
40. Brazil Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
41. Middle East and Africa Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
42. Middle East and Africa Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
43. UAE Blood Glucose Monitoring SystemsMarket, By Product, 2017-2027 (USD Billion) (K Units)
44. UAE Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
45. South Africa Blood Glucose Monitoring Systems Market, By Product, 2017-2027 (USD Billion) (K Units)
46. South Africa Blood Glucose Monitoring Systems Market, By End-User, 2017-2027 (USD Billion) (K Units)
List of Figures
1. Global Blood Glucose Monitoring Systems MarketSegmentation
2. Global Blood Glucose Monitoring Systems Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Blood Glucose Monitoring Systems Market Attractiveness Analysis By Product
9. Global Blood Glucose Monitoring Systems Market Attractiveness Analysis By End-User
10. Global Blood Glucose Monitoring Systems Market Attractiveness Analysis By Region
11. Global Blood Glucose Monitoring Systems Market: Dynamics
12. Global Blood Glucose Monitoring Systems Market Share by Product(2020 & 2027)
13. Global Blood Glucose Monitoring Systems Market Share by End-User (2020 & 2027)
14. Global Blood Glucose Monitoring Systems Market Share by Regions (2020 & 2027)
15. Global Blood Glucose Monitoring Systems Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.